A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

Phase 3

Completed

• Conditions: Glaucoma, Open-Angle; Ocular Hypertension

• Registration Number: NCT00051155
• Lead Sponsor: Alcon Research

Brief Summary

To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-01
• Study First Submitted: 2003-01-03
• Study First Submitted QC: 2003-01-06
• Study First Posted: 2003-01-07
• Primary Completion: 2004-07
• Study Completion: 2004-07
• Status Verified: 2008-08
• Last Update Submitted: 2008-08-04
• Last Update Posted: 2008-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Europe; 🇺🇸 Fort Worth, Texas, United States